Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

Herve Hoppenot

CEOHerve Hoppenot

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

11.26B

Market cap11.26B

Price-Earnings ratio

375.79

Price-Earnings ratio375.79

Dividend yield

—

Dividend yield—

Average volume

2.39M

Average volume2.39M

High today

$58.69

High today$58.69

Low today

$57.08

Low today$57.08

Open price

$58.01

Open price$58.01

Volume

1.17M

Volume1.17M

52 Week high

$83.95

52 Week high$83.95

52 Week low

$50.35

52 Week low$50.35

INCY News

TipRanks 6h

Incyte price target raised to $87 from $86 at BofA

BofA analyst Tazeen Ahmad raised the firm’s price target on Incyte (INCY) to $87 from $86 and keeps a Buy rating on the shares. The firm updated models in smid-...

Analyst ratings

64%

of 28 ratings

Buy

32.1%

Hold

64.3%

Sell

3.6%